Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy? by Aungier, S, Cartwright, A, Schwenzer, A, Marshall, J, Dyson, M, Slavny, P, Parthiban, K, Karatt-Vellatt, A, Sahbudin, I, Culbert, E, Hextall, P, Clanchy, F, Williams, R, Marsden, B, Raza, K, Filer, A, Buckley, C, McCafferty, J, Midwood, K

Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al. by Aungier, S, Cartwright, AJ, Schwenzer, A, Marshall, J, Dyson, MR, Slavny, P, Parthiban, K, Karatt-Vellatt, A, Sahbudin, I, Culbert, E, Hextall, P, Clanchy, FI, Williams, R, Marsden, BD, Raza, K, Filer, A, Buckley, CD, McCafferty, J, Midwood, KS